Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1070141 | Drug and Alcohol Dependence | 2012 | 6 Pages |
Abstract
Methadone and buprenorphine treatment provided in the public sector may attract different patient subpopulations. Providing buprenorphine treatment through drug treatment programs co-located with a health and mental health center may have accounted for their higher rates of medical and psychiatric problems and appears to be useful in attracting a diverse group of patients into public-sector funded treatment.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Shannon Gwin Mitchell, Sharon M. Kelly, Jan Gryczynski, C. Patrick Myers, Jerome H. Jaffe, Kevin E. O'Grady, Yngvild K. Olsen, Robert P. Schwartz,